It has been hypothesized that the loss of Maspin in metastatic melanoma tumor specimens might be attributed to an increase in p53, as there is evidence showing overexpression of p53 in metastatic melanoma specimens [82-84]. Here, SERPINB5 is linked to metastatic melanoma.